Alpha memo: resveratrol exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Include the actual results/findings from Receipt 2 to support the claim that the effect was reversed or failed in humans.
2. Replace the 'Why this is surprising' section with a substantive synthesis of how the rat data and human data differ.
3. Explicitly state the endpoints and outcomes for both populations to justify the 'cross-context' signal.

Major issues

• The central claim of the memo is that the signal 'fails, reverses, or splits' when moving from rats to humans, but the provided evidence for the human study (Receipt 2) is only an abstract/introduction that describes the study's purpose and methods; it does not report the actual results. Therefore, the 'failure' or 'reversal' is an unsupported claim.
• The manuscript lacks a coherent synthesis, presenting only a 'one-sentence alpha' and two receipts without analyzing the data or explaining the nature of the 'split' beyond a vague geometric label.

Minor issues

• The 'one-sentence alpha' is phrased as a sequence of titles rather than a research signal.

Reviewer note

The memo claims a 'mechanism_to_human_failure' signal, asserting that resveratrol's anti-inflammatory effects in rats (Receipt 1) do not translate to humans (Receipt 2). However, the provided text for Receipt 2 contains only the background, purpose, and methods of the study; it contains no results. The author has claimed a reversal of effect without providing the evidence of that reversal. Furthermore, the memo lacks any actual synthesis or analysis, serving only as a list of two citations. Because the central claim is materially unsupported by the provided source bundle, the memo is rejected.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: primary_failed_sparring_used

Prompt: reviewer-v11-research-synthesis